In addition, PORCN inhibition was previously shown to block the anti-adipogenic and pro-osteoblastic effects of another agent used for cancer treatment, 5-Aza-dC,32 suggesting that adipogenic induction at the expense of osteoblastogenesis is a common effect of treatment with these agents. Here, PORCN is linked to cancer.